Nanotherapeutics

Drug Delivery Concepts in Nanoscience
1. Auflage 2008
ISBN: 978-981-4241-02-1
Verlag: Pan Stanford Publishing

Buch, Englisch, 292 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 582 g

This timely book provides an overview of possible therapeutic applications. The first part of the book highlights general properties of and phenomena observed with nanoparticles, and the subsequent consequences for applications in drug delivery. The second part focuses on the therapeutic approaches that are possible through the use of nanoparticles, with each chapter discussing a specific disease (e.g., diabetes, cancer, inflammation) and the relevant therapeutic approaches based on the design of nanoparticulate drug delivery systems. From this concise book, readers will gain an insight into the basics of nanoparticle preparation and find a more detailed account of what is therapeutically feasible by using nanoparticle approaches.

Zielgruppe

Academic and Postgraduate

Autoren/Hrsg.

Lamprecht, Alf

Fachgebiete

• Naturwissenschaften Biowissenschaften Biowissenschaften
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
• Technische Wissenschaften Maschinenbau | Werkstoffkunde Technische Mechanik | Werkstoffkunde
• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Biotechnologie Medizinische Biotechnologie

Inhaltsverzeichnis

Preface, Part I: General Aspects of Nanotherapeutics, Part II: Disease-Related Approaches by Nanotherapeutics, Index

Über Autor(innen)

Alf Lamprecht studied pharmacy at the Saarland University in Saarbrucken, Germany, where he also received his PhD in 2001. After postdoctoral fellowships at the University of Angers, France, and the Gifu Pharmaceutical University, Japan, he was appointed assistant professor at the University of Nancy, France, before he became professor of pharmaceutical engineering at the University of Franche-Comté in Besancon, France, in 2005.

He is a member of the Controlled Release Society (CRS), the American Association of Pharmaceutical Sciences (AAPS), the German Pharmaceutical Society (DPhG) and Academy of Pharmaceutical Science and Technology, Japan (APSTJ). He serves as a member of the editorial board of Drug Development and Industrial Pharmacy. He received the Carl Wilhelm Scheele Prize of the German Pharmaceutical Society (DPhG) in 2001 and the Krka Award (Slovenia) and Eduard-Martin Award (Germany) in 2002.